Vivoryon Therapeutics
Halle, Germany· Est. 1997
Vivoryon Therapeutics is a precision medicine company focused on bringing first-in-class therapies to patients suffering from age-related diseases.
Private Company
Total funding raised: $230M
About
Vivoryon Therapeutics is a precision medicine company focused on bringing first-in-class therapies to patients suffering from age-related diseases.
Small Molecules
Funding History
6Total raised:$230M
PIPE$30MMar 15, 2023
Series B$60MDec 15, 2022
PIPE$20MJun 15, 2022
IPO$50MJul 14, 2021